Refresh

Control Print Ltd.

Price on BSE   21 Sep,10:43 LIVE
602.80
+4.50
(+0.75%)

© 2026 Rediff.com
  • Volume :
  • 666.00
  • Prev Close :
  • 598.30
  • Day's H/L (Rs.) :
  • 603.35 - 598.05
  • 52wk H/L (Rs.) :
  • 893.65 - 517.50
  • Mkt Cap (Rs. Cr) :
  • 964.49
Price on NSE   21 Sep,12:15 LIVE
601.30
+0.40
(+0.07%)

© 2026 Rediff.com
  • Volume :
  • 10,838.00
  • Prev Close :
  • 600.90
  • Day's H/L (Rs.) :
  • 606.90 - 593.00
  • 52wk H/L (Rs.) :
  • 899.00 - 517.00
  • Mkt Cap (Rs. Cr) :
  • 0.00
Report Card - Control Print Ltd.
PE Ratios
11.92
EPS (Rs.)
50.21
Sales (Rs. Cr)
104.63
Face Value (Rs.)
10
Net Profit Margin(%)
18.00
Last Bonus
1:2
Last Dividend(%)
60
Return on Average Equity
16.05

News for Control Print Ltd.

GLP-1 Drugs: Centre Directs Tighter Monitoring & Ad Scrutiny
Centre orders strict monitoring of GLP-1 drugs in India due to concerns over surrogate advertising and misleading promotions for weight loss.
Aug 04, 2026 16:13
IndiGo''s Next Flight Plan: Global Push, Diaspora Traffic
IndiGo charts its next 20 years with a global push, aiming to connect the Indian diaspora worldwide and recapture international traffic through India.
Aug 02, 2026 14:34
Amazon Expands Automation in India Fulfilment Centres
Amazon expands automation & robotics in India''s fulfilment centres, deploying advanced systems for inventory management. Company invests billions, eyes efficiency.
Jun 14, 2026 11:01
RBI''s Inflation Forecast Signals 1-2 Rate Hikes: Experts
RBI''s raised inflation forecast suggests 1-2 rate hikes are coming, say experts. Central bank kept repo rate unchanged but eyes future policy actions amid global risks.
Jun 05, 2026 15:23
Agnikul Tests 3D-Printed Agnite Booster Engine
Agnikul Cosmos successfully tests its 3D-printed 'Agnite' booster engine, reducing production complexity and turnaround time.
Mar 25, 2026 17:35

More News for Control Print Ltd. »

News for IT Equipments & Peripherals

Biocon's Pebrilzo Gets Positive EMA Panel Nod for Breast Cancer
Biocon Biologics' Pebrilzo, a Pertuzumab biosimilar for HER2-positive breast cancer, receives positive EMA panel recommendation, moving closer to EU approval.
Sep 21, 2026 12:10
Moneyview IPO Opens Sep 24: Price Band Fixed at Rs 32-34/Share
Digital lending platform Moneyview launches its Rs 1,092-crore IPO on September 24, with shares priced at Rs 32-34. Listing on NSE and BSE on Oct 1.
Sep 21, 2026 11:59
Manika Plastech Shares Debut Flat, Then Drop 5%
Manika Plastech shares debuted at Rs 43, matching issue price, but later fell 5% to Rs 40.85. The IPO was subscribed 28.14 times.
Sep 21, 2026 11:47
US-China Talks on Tariffs, AI Ahead of Xi-Trump Meeting
US and Chinese officials held 'candid' talks on economic, trade, and AI issues, including tariffs and Russia sanctions, ahead of President Xi Jinping's visit to Washington.
Sep 21, 2026 10:50
Premier Energies Commissions India's Largest Solar Cell Plant
Premier Energies has commissioned India's largest solar cell manufacturing plant in Andhra Pradesh, increasing its total capacity to 10.6 GW with a Rs 3,293 crore investment.
Sep 21, 2026 10:23

More News »

Top News

Biocon's Pebrilzo Gets Positive EMA Panel Nod for Breast Cancer
Biocon Biologics' Pebrilzo, a Pertuzumab biosimilar for HER2-positive breast cancer, receives positive EMA panel recommendation, moving closer to EU approval.
Sep 21, 2026 12:10
Moneyview IPO Opens Sep 24: Price Band Fixed at Rs 32-34/Share
Digital lending platform Moneyview launches its Rs 1,092-crore IPO on September 24, with shares priced at Rs 32-34. Listing on NSE and BSE on Oct 1.
Sep 21, 2026 11:59
Manika Plastech Shares Debut Flat, Then Drop 5%
Manika Plastech shares debuted at Rs 43, matching issue price, but later fell 5% to Rs 40.85. The IPO was subscribed 28.14 times.
Sep 21, 2026 11:47
Himadri Speciality Chemicals Board Approves Tyre Business Demerger
Himadri Speciality Chemicals' board approved the demerger of Dalmia Bharat Refractories' tyre business. HSCL will issue new shares, pending regulatory approvals.
Sep 21, 2026 11:43
US-China Talks on Tariffs, AI Ahead of Xi-Trump Meeting
US and Chinese officials held 'candid' talks on economic, trade, and AI issues, including tariffs and Russia sanctions, ahead of President Xi Jinping's visit to Washington.
Sep 21, 2026 10:50

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com